Discovery | Replication | P value | ||
---|---|---|---|---|
GRECOS | BASICMAR | |||
Subjects(n) | 59 | 584 | 62 | |
Sex | 0.429 | |||
Male, n (%) | 49 (17%) | 322 (55.2%) | 32 (51.6%) | |
Female, n (%) | 10 (83%) | 262 (44.8%) | 30 (48.4%) | |
Age in years, median (IQR) | 71 (15) | 77 (14) | 77 (9.5) | 0.22 |
NIHSS at baseline, median (IQR) | 3 (6.5) | 5 (8) | 15 (11.5) | < 2.2 × 10–16* |
NIHSS at discharge, median (IQR) | 1 (2) | 3 (6) | 4 (12) | 2.62 × 10–06* |
ΔNIHSS, median (IQR) | 1 (4) | 1 (4) | 5 (11) | 6.6 × 10–04* |
mRS 90 days, median (IQR) | 1 (3) | 2 (3) | 1 (3) | 5.4 × 10–04* |
Presence of HTN, n (%) | 37 (62.7%) | 236 (40.1%) | 40 (64.5%) | 1.04 × 10–03* |
Smoking, n (%) | 13 (22%) | 168 (28.8%) | 6 (9.67%) | 3 × 10–07* |
Presence of AF, n (%) | 3 (5%) | 201 (34.4%) | 25 (40.3%) | 2.86 × 10–02* |
Presence of DM, n (%) | 17 (28.8%) | 421 (72.1%) | 8 (12.9%) | 9.5 × 10–11* |
Treatment with rtPA, n (%) | 9 (15.3%) | 91 (15.6%) | 53 (85.5%) | < 2.2 × 10–16* |
TOAST | ||||
CES, n (%) | 0 (0%) | 231 (53.9%) | 29 (46.7%) | < 2.2 × 10–16* |
LAS, n (%) SVS, n (%) Und, n (%) Other, n (%) NA | 26 (44.1%) 11 (18.6%) 21 (35.6%) 1 (1.7%) 0 (0%) | 153 (39.6%) 194 (33.2%) 4 (0.7%) 2 (0.34%) 0 (0%) | 17 (27.4%) 0 (0%) 13 (2.1%) 0 (0%) 3 (4.8%) |